About Luna
Luna by Ablatus is a patented radiofrequency ablation technology enhanced by direct electrical current.
It offers the potential for incisionless, fertility-preserving, same-day procedures, with better outcomes and experience for patients and a more cost-effective option for health systems.
Ablatus is a spinout from the Norfolk and Norwich University Hospitals NHS Foundation Trust in the UK. We are backed by experienced angels and VC investors.
Our Mission
To revolutionise uterine health with minimally invasive and inclusive care
Our Technology
Luna is built on our patented technology, specifically designed for:
effective ablations
with a steerable probe
and outcomes
systems
Why Luna?
Better
- Fertility-preserving
- Incisionless
- More effective ablation of larger fibroids
- Improved access to hard-to reach fibroids
- Less discomfort using thinner & flexible probe
- Simpler design and application, less risks of device-related adverse effects
Faster
- Shorter procedural time
- Quicker access to treatment via outpatient than inpatient procedures
- Back to work within days instead of weeks as with open surgery
Cost-effective
- Lower device and operating costs
- Delivered in outpatient instead of inpatient setting
- Fewer consumables
- Compatible with common, existing ultrasound systems
- Lower staff training requirements
Faster
Shorter procedural time
Quicker access to treatment via
outpatient than inpatient
procedures
Back to work within days instead of
weeks as with open surgery
Better
Fertility-preserving Incisionless
More effective ablation of larger
fibroids. Improved access to hard-
to reach fibroids. Less discomfort
using thinner & flexible probe
Simpler design and application.
Cost-Effective
Lower device and operating costs
Delivered in outpatient instead of inpatient setting
Fewer consumables
Compatible with common, existing ultrasound systems
Lower staff training requirements